Is Ikonisys SA halal to invest in?

According to Musaffa's Shariah screening methodology, Ikonisys SA (ALIKO.PA) is currently classified as DOUBTFUL as of September 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Ikonisys SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ikonisys SA using these criteria to determine its compliance status.

Can Muslims buy shares of Ikonisys SA?

Muslim investors may consider investing in Ikonisys SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Ikonisys SA classified as DOUBTFUL?

Musaffa determines the Shariah status of Ikonisys SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Ikonisys SA updated?

The Shariah compliance status of Ikonisys SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Ikonisys SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Ikonisys SA?

You can check the latest Shariah compliance status of Ikonisys SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Ikonisys SA ALIKO.PA

€1.38 €0.09 (6.12%) 1D

Last Updated: May 15, 12:00 AM·XPAR

ALIKO.PA Shariah Compliance

Screening Methodology: AAOIFI

DOUBTFUL

Last Updated: September 12, 2024

Report Source: 2023 Annual Report

Analyst's Ratings for Ikonisys SA (ALIKO.PA)

Based on 9 analysts giving stock ratings to Ikonisys SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Ikonisys SA. Stock Analysis ALIKO.PA

France Health Care Nano Cap Report: 2023 Annual

Ikonisys SA specializes in the design, manufacture, and distribution of cellular diagnosis applications for cancer, genetic diseases, and fertility problems. The company is headquartered in Paris, Ile-De-France and currently employs 10 full-time employees. The company went IPO on 2021-07-19. The firm offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. The company utilizes advanced molecular and immunological markers, Ikoniscope robotic components, software engine, image acquisition, digital microscope and cell detection to design and deliver accurate and reliable detection of rare cells. The company includes clinical diagnostic applications for the diagnosis of different types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH her2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK) and a variety of hematological cancers utilizing the Explorer applications.

Key Statistics of Ikonisys SA (ALIKO.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€1.38€1.56

Today's Open

€1.47

Volume

17.49K

P/E Ratio (TTM)

52 Week Range

€1.36€1.84

Market Cap

22.10M

Avg. Volume

5047.55

Dividend Yield

Financial Metrics & Statements of Ikonisys SA (ALIKO.PA)

FAQ's for Ikonisys SA (ALIKO.PA)

According to Musaffa’s Shariah screening methodology, Ikonisys SA (ALIKO.PA) is currently classified as DOUBTFUL as of September 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.